Biospecimen Contract Research Services Market Drivers Include Rising Chronic Disease Burden And Demand For High Quality Samples

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Biospecimen Contract Research Services Market – (By Biospecimen Types (Oncological Studies, (FFPE Tissue, Frozen Tissue, Plasma / Serum, Other Biospecimens), Non-Oncological Studies (Blood Products, Human Tissue, Other Biospecimens)), By Therapeutic Area (Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Other Therapeutic Areas)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”
The Biospecimen Contract Research Services Market Size is valued at USD 5.0 billion in 2024 and is predicted to reach USD 17.7 billion by the year 2034 at a 13.6% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC:
Biospecimen contract research services provide access to high-quality biological materials-such as tissue samples, blood, and DNA-supplemented with associated clinical data to support research in fields including oncology, immunology, and genetics. These services encompass the complete management of specimen collection, processing, storage, and quality assurance, with strict compliance to ethical and regulatory standards. Market growth is being driven by the increasing demand for reliable biospecimens, the need for research organizations to augment internal capabilities, and the growing focus on personalized medicine as a cornerstone of modern healthcare.
List of Significant Players in the Biospecimen Contract Research Services Market:
-
Boca Biolistics
Creative Bioarray
BioChain Institute,
BioIVT
Cureline
Discovery Life Sciences
Infinity BiologiX
Precision for Medicine, Inc.
PrecisionMed, Inc.
Medicover
National BioService
ICON plc
iProcess Global Research Inc.
ABS Inc.
The MT Group
Eolas Biosciences Co. Ltd
Indivumed GmbH
Ardent Clinical Research Services
Capital Biosciences, Inc.
iSpecimen
GR BioResearch
REPROCELL
Trans-Hit Bio (Azenta US, Inc.)
Expert Knowledge, Just a Click Away:
Market Dynamics
Drivers:
The global biospecimen contract research services (BCRS) market is experiencing robust growth, driven by the rising prevalence of chronic diseases, the increasing adoption of personalized medicine, and expanding investments in pharmaceutical research and development. BCRS play a vital role in meeting the growing demand for diverse, well-characterized biospecimens that are essential for studying disease mechanisms, identifying biomarkers, and advancing targeted therapies. Additionally, the aging global population is amplifying the need for these services to support research on age-related conditions, thereby fostering significant growth in healthcare-related R&D activities.
Challenges:
Despite promising growth prospects, the market faces several constraints, including a shortage of skilled professionals, complex regulatory requirements, and the absence of standardized protocols for specimen collection, quality control, and safety assurance. The industry's competition for qualified talent across pharmaceutical, biotechnology, and academic institutions remains intense, often requiring providers to offer competitive compensation packages, which can strain operational budgets-particularly for smaller organizations. Moreover, the global lack of specialized training programs continues to create a gap between workforce capabilities and industry needs, hindering broader market expansion.
Regional Trends:
North America is expected to maintain its leading position in the BCRS market, supported by the strong presence of pharmaceutical and biotechnology companies, advanced clinical research infrastructure, and a mature healthcare ecosystem. The growing trend of outsourcing research activities by pharmaceutical firms, combined with substantial R&D investments, further reinforces regional dominance. Europe also represents a significant market, fueled by increasing R&D expenditure across industries such as pharmaceuticals and nanotechnology, which is contributing to the steady adoption of BCRS across the region.
Unlock Your GTM Strategy:
Recent Developments:
-
In Feb 2023, iSpecimen strategically expanded its own marketplace platform by incorporating seven new biospecimen sample providers from the U.S. and Europe. The additional suppliers enabled iSpecimen to provide worldwide access to essential biospecimens and data necessary for advancing research in oncology, autoimmune diseases, infectious diseases, cardiovascular diseases, and other areas.
Segmentation of Biospecimen Contract Research Services Market-
By Biospecimen Type-
-
Oncological Studies
-
FFPE Tissue
Frozen Tissue
Plasma / Serum
Other Biospecimens
-
Blood Products
Human Tissue
Other Biospecimens
By Therapeutic Area-
-
Oncological Disorders
Neurological Disorders
Cardiovascular Disorders
Other Therapeutic Areas
By Region-
North America-
-
The US
Canada
Mexico
Europe-
-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
-
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America-
-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
-
GCC Countries
South Africa
Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Tags: Biospecimen Contract Research Services Market See Campaign:Contact Information:
Contact us: InsightAce Analytic Pvt. Ltd. Visit: Tel : +1 607 400-7072 Asia: +91 79 72967118 ...
Tags:CE , Go Media , Go Media2 , iCN Internal Distribution , Reportedtimes , Research Newswire , English

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Alt.Town Introduces $TOWN Token Utility Across Platform Services And Launches Valuefi Deposit Event
- BTCC Exchange Maintains 143% Total Reserve Ratio In September 2025 Demonstrating Continued Financial Strength
- Salvium Solves The Privacy Paradox: Salvium One Delivers Mica-Compliant Privacy That Exchanges Can List
- Zebu Live 2025 Welcomes Coinbase, Solana, And Other Leaders Together For UK's Biggest Web3 Summit
- Tapbit At TOKEN2049: Reshaping The Crypto Landscape Through Product Innovation
- Thrivestate Launches“Fly Before You Buy” Program, Enabling International Buyers To Explore Dubai Before Committing
Comments
No comment